Jill Carroll is an Operating Partner at SR One, a transatlantic biotech venture capital firm. See sector focus and contact routes.
Jill Carroll is an Operating Partner at SR One, a transatlantic biotech venture capital firm, where she has managed key investments since joining in 2011. Her investment focus centers on innovative life sciences companies advancing new medicines to address critical patient needs, with a track record in Series A, B, and C funding rounds across the biotechnology sector. Carroll typically leads investments, having directed significant portfolio companies including Arcellx (ACLX), Odyssey, and Avalyn Pharma. Notable named portfolio companies under her oversight include Arcellx, a cell therapy company where she serves as an independent director, as well as Odyssey, Avalyn, and HotSpot Therapeutics. She holds a BS in Chemistry from Duke University and an MS in Biochemistry from Johns Hopkins University, complementing her prior experience in strategy consulting and biotech corporate development at Dynavax Technologies. While her public writing or distinctive point of view is not detailed in available sources, her operational role includes developing SR One’s junior investing team alongside her investment responsibilities.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Virginia.
Investors like Jill Carroll · Full investor directory · Investor access · Company funding database